On April 4, 2022 IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX platform to treat solid and hematologic cancers, reported that members of IMV’s executive management team will be participating in the 21st Annual Needham Virtual Annual Healthcare Conference, which will be held April 11-14, and the Wells Fargo Biotech Forum, which will be held April 12-13 (Press release, IMV, APR 4, 2022, View Source [SID1234611383]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

21st Annual Needham Virtual Healthcare Conference
Format: Presentation and one-on-one investor meetings
Date: Thursday April 14, 2022
Time: 12:45 p.m. ET
Webcast: Click Here

Wells Fargo Biotech Forum
Format: One-on-one investor meetings
Date: April 12-13

A replay for the 21st Annual Needham Virtual Annual Healthcare Conference presentation will be available in the ‘Events, Webcasts & Presentations’ section of IMV’s website for 90 days.